Posted by Michael Wonder on 31 May 2022
Schedule of Pharmaceutical Benefits - 1 June 2022
1 June 2022 - The June 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The June issue of the Schedule includes a few new/revised listings:
- Bortezomib (Bortezomib Ever Pharma) - new formulation
- Rituximab (Ruxience) - new biosimilar medicine
- Venetoclax (Venclexta) - new presentation
Read Summary of Changes
Posted by:
Michael Wonder